You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Claims for Patent: 8,252,929


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,252,929
Title:8-carboxamido-2,6-methano-3-benzazocines
Abstract: 8-Substituted-2,6-methano-3-benzazocines of general structure I in which A is --CH.sub.2--OH, --CH.sub.2NH.sub.2, --NHSO.sub.2CH.sub.3, ##STR00001## and Y is O, S or NOH are useful as analgesics, anti-diarrheal agents, anticonvulsants, antitussives and anti-addiction medications. ##STR00002## 8-Carboxamides, thiocarboxamides, hydroxyamidines and formamides are preferred.
Inventor(s): Wentland; Mark P. (Watervliet, NY)
Assignee: Rensselaer Polytechnic Institute (Troy, NY)
Application Number:13/103,599
Patent Claims: 1. A compound of formula: ##STR00034## wherein A is ##STR00035## Y is chosen from O and S; R.sup.1 is --NHR.sup.8; R.sup.2 and R.sup.2a are both hydrogen or taken together R.sup.2 and R.sup.2a are .dbd.O; R.sup.3 is chosen from hydrogen, lower alkyl, alkenyl, aryl, heterocyclyl, benzyl and hydroxyalkyl; R.sup.4 is chosen from hydrogen, hydroxy, amino, lower alkoxy, C.sub.1-C.sub.20 alkyl and C.sub.1-C.sub.20 alkyl substituted with hydroxy or carbonyl; R.sup.5 is lower alkyl; R.sup.6 is lower alkyl; R.sup.7 is chosen from hydrogen and hydroxy; or together R.sup.4, R.sup.5, R.sup.6 and R.sup.7 may form from one to three rings, said rings having optional additional substitution; and R.sup.8 is hydrogen.

2. A compound according to claim 1 wherein A is chosen from the group consisting of: --CONH.sub.2 and --C(.dbd.S)NH.sub.2.

3. A 2,6-methano-3-benzazocine according to claim 1 wherein: R.sup.4 is chosen from hydrogen, hydroxy, lower alkoxy, C.sub.1-C.sub.20 alkyl and C.sub.1-C.sub.20 alkyl substituted with hydroxy or carbonyl; R.sup.5 is lower alkyl; R.sup.6 is lower alkyl; and R.sup.7 is hydrogen or hydroxy.

4. A 2,6-methano-3-benzazocine according to claim 3 wherein: R.sup.3 is chosen from hydrogen, cyclopropyl, cyclobutyl, phenyl, vinyl, dimethylvinyl, hydroxycyclopropyl, furanyl, and tetrahydrofuranyl; R.sup.4 is chosen from hydrogen and 3-oxo-5-cyclopentyl-1-pentanyl; R.sup.5 is methyl; and R.sup.6 is methyl or ethyl.

5. A morphinan according to claim 1 wherein together R.sup.5, R.sup.6 and R.sup.7 form two rings, said morphinan having the structure: ##STR00036## wherein R.sup.4 is hydrogen, hydroxy, amino or lower alkoxy; R.sup.9 is hydrogen or lower alkyl; R.sup.10 is chosen from hydrogen, lower alkyl and hydroxy(lower alkyl); or together, R.sup.9 and R.sup.10 form a spiro-fused carbocycle of 5 to 10 carbons; R.sup.11 is hydrogen; R.sup.12 is chosen from hydroxy, lower alkoxy --NH.sub.2, --N(CH.sub.2CH.sub.2Cl).sub.2, and --NHC(O)CH.dbd.CHCOOCH.sub.3; or together, R.sup.11 and R.sup.12 form a carbonyl or a vinyl substituent; or together, R.sup.4 and R.sup.11 form a sixth ring.

6. A morphinan according to claim 5, wherein R.sup.4 and R.sup.11 form a sixth ring, of formula ##STR00037##

7. A morphinan according to claim 6 wherein R.sup.9 is hydrogen; R.sup.10 is hydroxy(lower alkyl); and R.sup.12 is lower alkoxy.

8. A morphinan according to claim 5, wherein R.sup.11 and R.sup.12 form a carbonyl substituent, of formula: ##STR00038##

9. A morphinan according to claim 8 wherein R.sup.2 and R.sup.2a are both hydrogen; R.sup.4 is chosen from hydrogen, hydroxy, amino and lower alkoxy; and R.sup.9 and R.sup.10 are both hydrogen or together, R.sup.9 and R.sup.10 form a spiro-fused carbocycle of 5 to 10 carbons.

10. A morphinan according to claim 9 wherein R.sup.9 and R.sup.10 are both hydrogen.

11. A morphinan according to claim 5, wherein R.sup.11 and R.sup.12 form a vinyl substituent, of formula: ##STR00039##

12. A morphinan according to claim 11 wherein R.sup.2 and R.sup.2a are both hydrogen; R.sup.4 is hydroxy; and R.sup.9 and R.sup.10 are both hydrogen.

13. A morphinan according to claim 5 wherein R.sup.2 and R.sup.2a are both hydrogen; R.sup.4 is hydroxy; R.sup.9 and R.sup.10 are both hydrogen; and R.sup.12 is chosen from: --NH.sub.2, --N(CH.sub.2CH.sub.2Cl).sub.2, and --NHC(O)CH.dbd.CHCOOCH.sub.3.

14. A morphinan according to claim 1 wherein together R.sup.5, R.sup.6 and R.sup.7 form two rings, said morphinan having the structure: ##STR00040##

15. A morphinan according to claim 5, wherein R.sup.4 and R.sup.11 form a sixth ring, of formula ##STR00041## wherein R.sup.9 is hydrogen; R.sup.10 is hydroxy(lower alkyl); and R.sup.12 is lower alkoxy.

16. A 3-carboxamide substituted morphinan compound.

17. The morphinan compound of claim 16 having the formula: ##STR00042## Wherein, R.sup.2 and R.sup.2a are both hydrogen; R.sup.3 is chosen from hydrogen, lower alkyl, alkenyl, aryl, heterocyclyl, benzyl and hydroxyalkyl; R.sup.4 hydroxyl; and, R.sup.9 and R.sup.10 are both hydrogen.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.